Millipore Forms Collaboration with Agilent Technologies to Expand Capabilities in Epigenetics Research Market
Millipore Corporation and Agilent Technologies Inc. announced they have formed a collaboration to develop ChIP (chromatin immunoprecipitation) kits for the fast-growing epigenetics research market. The kits will be designed to improve protein researchers’ productivity and simplify the way they study genetic information. ChIP is a technique that helps researchers understand the relationship between DNA and the proteins that impact gene regulation.
“This collaboration brings together two industry leaders to improve scientific workflows for epigenetic researchers,” said Geoffrey Crouse, Vice President of Millipore’s Life Science Strategic Business Unit. “Our long history of leadership in the ChIP market coupled with Agilent’s leadership in DNA microarrays will enable us to help scientists push the frontiers of epigenetic research. We expect to help epigenetics researchers minimize the barriers of entry into chromatin state mapping, readily obtain reproducible genomic profiling data, and overcome the traditional challenges of ChIP assays.”
Other news from the department business & finance
